Manuka, Inc. (MNKA)

0.0400 0.0000 (0.00%) As of 01:46PM EDT. Market open.

Manuka, Inc.

3 Eliezer Vardinon Street
Suite 701
Petah Tikva 4959507
Israel
972 7 7407 4700
https://bmanuka.co.il

Sector(s): Consumer Defensive
Industry: Household & Personal Products
Full Time Employees: 4

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Shimon Citron	CEO & Director	134k	N/A	1956
Mr. David Dana	Chief Financial Officer	23k	N/A	1965
Mr. Haim Tabak	COO & Consultant	66k	N/A	1947

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Artemis Therapeutics Inc., a beauty company, engages in the development and distribution of skincare products in Israel. The company offers face serum with manuka honey and bee venom, face serum with vitamin C, day cream, nourishing night cream with manuka honey and nee venom, eye cream with manuka honey and bee venom, and face cleanser gel. It also distributes manuka honey imported from New Zealand. The company was incorporated in 2020 and is based in Ramat Gan, Israel.

Corporate Governance

Manuka, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.